Does SelectHealth Cover Ritalin?

The Answer Depends on Which Select Health Formulary You Have

Select Health uses more than one drug list. Its member pharmacy page says a commercial member's formulary is generally RxCore or RxSelect, and the name appears in the member account and on the ID card. Coverage can also differ for Medicare and Select Health Community Care members [1].

That distinction matters because "methylphenidate" describes a family of products, not one interchangeable formulary entry. A drug list may separate:

• immediate-release tablets;
• chewable tablets or oral solution;
• extended-release tablets;
• extended-release capsules;
• osmotic-release tablets;
• transdermal patches; and
• brand-name products such as Ritalin or Ritalin LA.

The easiest and most accurate check is the signed-in Select Health drug search. Select Health says the member account shows whether a drug is covered and how the specific plan covers it [1].

What Current 2026 Formularies Show

The current public documents support coverage for generic methylphenidate, but they also show why one blanket answer would be misleading.

Utah RxCore

The Utah RxCore prescription drug list published July 23, 2026 lists generic methylphenidate hydrochloride tablets, chewable tablets, solutions, and multiple extended-release forms on Tier 2, each with a quantity-limit code [2].

The document is a summary of commonly prescribed covered drugs, not the member's complete formulary. It directs members to the signed-in tool for the complete list, exact cost, and any preauthorization or other coverage steps.

RxSelect Four Tier

The RxSelect four-tier list published June 1, 2026 places most listed generic methylphenidate hydrochloride immediate- and extended-release products on Tier 1 with quantity limits. It separately lists some other methylphenidate products at different tiers or with step therapy [3].

This is a concrete example of formulary variation: the same active ingredient can have a different tier depending on the drug list and dosage form.

Select Health Medicare Essential

The 2026 Select Health Medicare Essential formulary for Colorado, Nevada, and Utah lists covered generic methylphenidate hydrochloride immediate- and extended-release products on Tier 3 with explicit, form-specific quantity limits [4].

Brand-name Ritalin does not appear in these public summary searches. That does not by itself prove a universal exclusion, because commercial summary lists are not the complete member formulary and Medicare products can vary. Search the brand and generic separately in the member account or ask Pharmacy Services to check the exact National Drug Code and dosage form.

How to Check Ritalin Coverage

Use this sequence to avoid an unnecessary pharmacy rejection:

1. Sign in to the Select Health member account.
2. Confirm whether the plan uses RxCore, RxSelect, Medicare, or Community Care.
3. Search methylphenidate hydrochloride and Ritalin separately.
4. Match the exact immediate-release or extended-release product, strength, and dosage form.
5. Note the tier and any PA, ST, QL, or AGE code.
6. Price the prescription at the intended pharmacy.
7. If the result is unclear, call the number on the member ID card.

In Select Health documents, PA means preauthorization, ST means step therapy, QL means quantity limit, and AGE means an age requirement. A quantity-limit code does not automatically mean the prescription will be denied; it means the plan covers only a defined amount unless an override is approved.

Does Select Health Require Prior Authorization?

The current Utah RxCore, RxSelect, and Medicare examples above show quantity limits, not a universal prior-authorization requirement, for the common generic methylphenidate entries. Other products, plans, strengths, or requested quantities can have different requirements.

Do not assume that Select Health requires:

• prior authorization for every adult;
• a urine drug screen;
• proof of symptoms before age 12 in every pharmacy submission;
• a fixed trial of immediate-release methylphenidate before any extended-release product; or
• one standard dose or refill schedule across all plans.

Those claims need support from the current criteria attached to the member's exact benefit. Select Health publishes separate lists of drugs with special requirements and uses PromptPA for drug preauthorization and noncovered-drug exception requests [5].

If a pharmacy rejects the claim, ask for the exact rejection message. It may indicate a quantity limit, refill timing, noncovered product, missing preauthorization, pharmacy-network issue, or another administrative reason.

What Ritalin Costs With Select Health

There is no single Select Health copay for Ritalin or methylphenidate. The member's cost can depend on:

• RxCore versus RxSelect;
• commercial, Medicare, or Medicaid coverage;
• drug tier;
• deductible status;
• copay versus coinsurance;
• immediate- versus extended-release formulation;
• brand versus generic;
• pharmacy network; and
• quantity and days' supply.

The tier is only one part of the calculation. A current Utah individual-plan comparison, for example, shows different tier copays, coinsurance, and pharmacy deductibles across 2026 plans [6]. Use the authenticated price tool rather than a national dollar range.

A cash discount may sometimes cost less than an insurance claim, but ask whether that purchase will count toward the plan deductible or out-of-pocket limit before choosing it.

Generic Methylphenidate Is Not One Formulation

FDA-approved generics must meet the agency's requirements for pharmaceutical equivalence, bioequivalence, quality, and manufacturing. FDA explains that a generic has the same active ingredient, strength, dosage form, and route of administration as its reference product, with limited permitted differences [7].

That does not mean every methylphenidate formulation is interchangeable. Immediate-release Ritalin, Ritalin LA, Concerta-type osmotic-release tablets, chewable products, solutions, and patches use different dosage forms or release systems. Coverage for one does not establish coverage for another.

FDA previously changed therapeutic-equivalence ratings for specific generic Concerta products after concerns about their release performance. FDA also states that action did not apply to other extended-release methylphenidate products such as Ritalin LA [8]. If a member has a concern about a specific manufacturer or formulation, the pharmacy can identify the dispensed manufacturer and the prescriber can document the clinical issue.

What to Do After a Coverage Denial

First distinguish a pharmacy rejection from a written adverse benefit determination.

For a rejection:

1. Ask the pharmacy for the exact code and message.
2. Ask Select Health whether a covered generic, different formulation, or different pharmacy would resolve it.
3. If a quantity limit was exceeded, ask how the prescriber can request an override.
4. If the product is noncovered, ask for the exception criteria and submission method.

For a denial:

1. Read the notice for the specific reason and deadline.
2. Address that reason directly with relevant records.
3. Include prior treatment outcomes or contraindications only when they are relevant and documented.
4. Keep the submission confirmation and a copy of the decision.

Select Health's general Appeals and Grievances page says members who receive an adverse benefit determination generally have 60 days to request an appeal [9]. Medicare Part D follows its own coverage-determination and redetermination rules; use the Medicare denial notice and Select Health Medicare appeal resources rather than assuming the commercial process applies [10].

FDA Status and Clinical Evidence

The 2025 FDA-approved labeling for immediate-release Ritalin tablets lists ADHD and narcolepsy as indications. Ritalin is a Schedule II controlled substance and carries a boxed warning about abuse, misuse, and addiction [11].

Methylphenidate is one evidence-supported treatment option for ADHD, but treatment choice is individualized. The American Academy of Pediatrics guideline addresses diagnosis and treatment of ADHD in children and adolescents, including FDA-approved medication and behavioral interventions based on age and circumstances [12]. The landmark Multimodal Treatment Study of Children with ADHD compared carefully managed medication, behavioral treatment, combined treatment, and community care [13].

Clinical evidence can help a prescriber explain medical necessity. It does not determine a member's tier, quantity limit, or exception outcome; those are governed by the current benefit and submitted facts.

Questions to Ask Select Health

• Which formulary applies to my plan?
• Is the exact generic methylphenidate product covered?
• Is brand-name Ritalin or Ritalin LA covered separately?
• What tier applies to this dosage form and strength?
• What is the exact quantity limit?
• Does the request require PA or ST?
• What will I pay at this pharmacy with my current deductible?
• If the product is not covered, how does my prescriber request an exception?
• If a request is denied, what appeal deadline and expedited process apply?